Options
The spinal muscular atrophy disease protein SMN is linked to the rho-kinase pathway via profilin
ISSN
0964-6906
Date Issued
2011
Author(s)
Noelle, Anna
van Bergeijk, Jeroen
Gerhard, Ralf
Brinkmann, Hella
Al Rayes, Sarah
Hensel, Niko
Schill, Yvonne
Apkhazava, David
Jablonka, Sibylle
O'mer, Jana
Srivastav, Ratnesh Kumar
Baasner, Anne
Wirth, Brunhilde
Ponimaskin, Evgeni G.
Niedenthal, Rainer
Grothe, Claudia
DOI
10.1093/hmg/ddr425
Abstract
Spinal muscular atrophy (SMA), a frequent neurodegenerative disease, is caused by reduced levels of functional survival of motoneuron (SMN) protein. SMN is involved in multiple pathways, including RNA metabolism and splicing as well as motoneuron development and function. Here we provide evidence for a major contribution of the Rho-kinase (ROCK) pathway in SMA pathogenesis. Using an in vivo protein interaction system based on SUMOylation of proteins, we found that SMN is directly interacting with profilin2a. Profilin2a binds to a stretch of proline residues in SMN, which is heavily impaired by a novel SMN2 missense mutation (S230L) derived from a SMA patient. In different SMA models, we identified differential phosphorylation of the ROCK-downstream targets cofilin, myosin-light chain phosphatase and profilin2a. We suggest that hyper-phosphorylation of profilin2a is the molecular link between SMN and the ROCK pathway repressing neurite outgrowth in neuronal cells. Finally, we found a neuron-specific increase in the F-/G-actin ratio that further support the role of actin dynamics in SMA pathogenesis.